Detalhe da pesquisa
1.
Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 403(10423): 249-260, 2024 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048786
2.
Safety of anticoagulation in patients with atrial fibrillation and MDS/AML complicated by thrombocytopenia: An unresolved challenge: Can they be managed? A report of three cases and literature review.
Am J Hematol
; 93(5): E112-E114, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29352736
3.
Ascertaining QUAZARs: slow-motion and light-speed development of oral azacitidine and decitabine.
Leuk Lymphoma
; 64(3): 525-539, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36370098
4.
A randomized trial of hypnosis for relief of pain and anxiety in adult cancer patients undergoing bone marrow procedures.
J Psychosoc Oncol
; 30(3): 281-93, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22571244
5.
Immunoglobulin repletion during blinatumomab therapy does not reduce the rate of secondary hypogammaglobulinemia and associated infectious risk.
Blood Res
; 57(2): 135-143, 2022 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35551109
6.
Forsaken Pharmaceutical: Glasdegib in Acute Myeloid Leukemia and Myeloid Diseases.
Clin Lymphoma Myeloma Leuk
; 21(4): e415-e422, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33547022
7.
Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies.
Hemasphere
; 5(4): e549, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33718803
8.
Myelodysplastic syndromes: a review of therapeutic progress over the past 10 years.
Expert Rev Anticancer Ther
; 20(6): 465-482, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32479130
9.
Myelo-deception: Luspatercept & TGF-Beta ligand traps in myeloid diseases & anemia.
Leuk Res
; 97: 106430, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32763582
10.
Rigosertib in combination with azacitidine in patients with myelodysplastic syndromes or acute myeloid leukemia: Results of a phase 1 study.
Leuk Res
; 94: 106369, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32442785
11.
Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts.
Lancet Haematol
; 7(8): e601-e612, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32563283
12.
A phase 1/2 study of rigosertib in patients with myelodysplastic syndromes (MDS) and MDS progressed to acute myeloid leukemia.
Leuk Res
; 64: 10-16, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29144985
13.
Safety and efficacy of azacitidine in elderly patients with intermediate to high-risk myelodysplastic syndromes.
Ther Adv Hematol
; 8(1): 21-27, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28042456
14.
The safety and efficacy of rigosertib in the treatment of myelodysplastic syndromes.
Expert Rev Anticancer Ther
; 16(8): 805-10, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27400247
15.
An Opportunity for Hospice Referral in Acute Myeloid Leukemia: Prognostic Significance of Hospitalization Status at Time of Second Cycle of Hypomethylating Agents for Patients Ineligible for Intensive Induction Chemotherapy.
J Palliat Med
; 23(11): 1424-1425, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33174777
16.
Severe Protein-Losing Enteropathy Due to an Indolent Splenic Lymphoma: Case Report and Review of the Literature.
Clin Lymphoma Myeloma Leuk
; 19(4): e165-e168, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30685184
17.
Clinical development of demethylating agents in hematology.
J Clin Invest
; 124(1): 40-6, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24382388
18.
Management of chemotherapy-induced neutropenic fever.
Hosp Pract (1995)
; 41(1): 96-108, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23466972
19.
Phase 1 study of intravenous rigosertib (ON 01910.Na), a novel benzyl styryl sulfone structure producing G2/M arrest and apoptosis, in adult patients with advanced cancer.
Am J Cancer Res
; 3(3): 323-38, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23841031
20.
Therapeutic modalities for patients with lower-risk myelodysplastic syndromes: current options and future directions.
Curr Hematol Malig Rep
; 6(1): 5-12, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21153773